Equities Analysts Offer Predictions for The Procter & Gamble Company’s Q1 2025 Earnings (NYSE:PG)

The Procter & Gamble Company (NYSE:PGFree Report) – Stock analysts at DA Davidson issued their Q1 2025 earnings per share (EPS) estimates for shares of Procter & Gamble in a report released on Thursday, October 10th. DA Davidson analyst L. Weiser anticipates that the company will post earnings of $1.90 per share for the quarter. DA Davidson currently has a “Neutral” rating and a $159.00 target price on the stock. The consensus estimate for Procter & Gamble’s current full-year earnings is $6.97 per share. DA Davidson also issued estimates for Procter & Gamble’s FY2025 earnings at $6.98 EPS and FY2026 earnings at $7.40 EPS.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.03. The firm had revenue of $20.53 billion for the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company’s revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.37 EPS.

Other equities research analysts have also recently issued reports about the company. Evercore ISI upped their target price on Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a report on Thursday, July 18th. Wolfe Research upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. Deutsche Bank Aktiengesellschaft upped their price objective on Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Piper Sandler assumed coverage on Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. Finally, Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Nine equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $176.21.

Read Our Latest Research Report on Procter & Gamble

Procter & Gamble Price Performance

Shares of PG stock opened at $172.64 on Monday. Procter & Gamble has a twelve month low of $142.50 and a twelve month high of $177.94. The stock has a market capitalization of $407.45 billion, a price-to-earnings ratio of 28.21, a P/E/G ratio of 3.67 and a beta of 0.41. The stock has a fifty day simple moving average of $171.57 and a two-hundred day simple moving average of $166.88. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51.

Hedge Funds Weigh In On Procter & Gamble

Hedge funds and other institutional investors have recently made changes to their positions in the company. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble during the second quarter worth approximately $28,000. Fairway Wealth LLC purchased a new position in Procter & Gamble during the second quarter worth approximately $29,000. Transcendent Capital Group LLC purchased a new position in Procter & Gamble during the fourth quarter worth approximately $31,000. Ruedi Wealth Management Inc. lifted its position in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after buying an additional 77 shares in the last quarter. Finally, POM Investment Strategies LLC purchased a new position in Procter & Gamble during the second quarter worth approximately $34,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling

In related news, CEO Jon R. Moeller sold 7,007 shares of the firm’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the sale, the chief executive officer now directly owns 269,172 shares of the company’s stock, valued at $46,203,373.80. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Procter & Gamble news, CEO Jon R. Moeller sold 7,007 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the transaction, the chief executive officer now owns 269,172 shares in the company, valued at approximately $46,203,373.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 383,194 shares of company stock valued at $65,140,718 over the last ninety days. Company insiders own 0.17% of the company’s stock.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.33%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is 65.69%.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

See Also

Earnings History and Estimates for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.